当前位置: 首页 > 期刊 > 《健康必读·下旬刊》 > 2019年第4期
编号:13345297
妈富隆联合米非司酮治疗早孕人流不全的价值体会(1)
http://www.100md.com 2019年4月1日 《健康必读·下旬刊》 2019年第4期
     【摘 要】目的:分析早孕人流不全采用妈富隆联合米非司酮治疗效果。方法:选择2017年12月至2018年12月期间我单位收治的86例早孕人流不全的患者,分为对照组和观察组,每组各为43例。对照组采用常规处理清宫术进行治疗,观察组采用妈富隆联合米非司酮治疗,将两组患者的治疗效果予以对比。结果:两组患者的阴道流血时间、尿妊娠试验转阴时间对比(P>0.05)无统计学意义;两组的康复率对比(P>0.05)无统计学意义;观察组盆腔炎发生率、宫腔粘连发生率低于对照组,(P<0.05)存在统计学意义。观察组LH、E2、FSH均低于对照组,(P<0.05)存在统计学意义。结论:采取妈富隆联合米非司酮治疗早孕人流不全具有明显效果,具备一定的安全性,值得临床上借鉴和进一步普及。

    【关键词】妈富隆;米非司酮;早孕;人流

    Abstract Objective: To analyze the effect of Marvelon combined with mifepristone in the treatment of early pregnancy. METHODS: Eighty-six patients with early pregnancy incompleteness admitted to our hospital from December 2017 to December 2018 were enrolled. The patients were divided into a control group and an observation group by drawing. Each group had 43 cases. The control group was treated with conventional treatment of Qinggong. The observation group was treated with Marvelon combined with mifepristone to compare the therapeutic effects of the two groups. RESULTS: There was no significant difference in vaginal bleeding time and urinary pregnancy test time between the two groups (P>0.05). There was no significant difference in the recovery rate between the two groups (P>0.05). The incidence of pelvic inflammatory disease in the observation group ......
1 2下一页

您现在查看是摘要页,全文长 3274 字符